Ablation of PI3K p110-α prevents high-fat diet-induced liver steatosis

Diabetes

Volumn 60, Issue 5, 2011, Pages 1483-1492

  Chattopadhyay, Mohar ^a   Selinger, Elzbieta S ^b   Ballou, Lisa M ^b   Lin, Richard Z ^a,b,c  

^a STONY BROOK UNIVERSITY   (United States)

^b STONY BROOK UNIVERSITY   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID BINDING PROTEIN; MESSENGER RNA; PALMITIC ACID; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3 KINASE SUBUNIT P110 ALPHA; PHOSPHATIDYLINOSITOL 3 KINASE SUBUNIT P110 BETA; PROTEIN KINASE C; PROTEIN P110; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENZYME SUBUNIT; FATTY ACID TRANSPORT; FATTY LIVER; GLUCONEOGENESIS; GLUCOSE INTOLERANCE; LIPID DIET; LIPID LIVER LEVEL; LIPID STORAGE; LIPOGENESIS; LIVER CELL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION;

ANIMALS; BLOTTING, WESTERN; CELLS, CULTURED; DIETARY FATS; FATTY LIVER; GLUCOSE TOLERANCE TEST; GLYCOGEN; INSULIN; LIVER; MICE; MICE, KNOCKOUT; PHOSPHATIDYLINOSITOL 3-KINASES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 79959446484     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db10-0869     Document Type: Article

References (35)

1. Angulo P. Nonalcoholic fatty liver disease. N Engl J Med 2002;346:1221-1231
2. Angulo P. GI epidemiology: nonalcoholic fatty liver disease. Aliment Pharmacol Ther 2007;25:883-889
3. Inoue M, Ohtake T, Motomura W, et al. Increased expression of PPAR-gamma in high fat diet-induced liver steatosis in mice. Biochem Biophys Res Commun 2005;336:215-222 (Pubitemid 41253423)
4. Lin J, Yang R, Tarr PT, et al. Hyperlipidemic effects of dietary saturated fats mediated through PGC-1beta coactivation of SREBP. Cell 2005;120:261-273 (Pubitemid 40174768)
5. Oosterveer MH, van Dijk TH, Tietge UJ, et al. High fat feeding induces hepatic fatty acid elongation in mice. PLoS ONE 2009;4:e6066
6. Doege H, Baillie RA, Ortegon AM, et al. Targeted deletion of FATP5 reveals multiple functions in liver metabolism: alterations in hepatic lipid homeostasis. Gastroenterology 2006;130:1245-1258
7. Falcon A, Doege H, Fluitt A, et al. FATP2 is a hepatic fatty acid transporter and peroxisomal very long-chain acyl-CoA synthetase. Am J Physiol Endocrinol Metab 2010;299:384-393
8. Newberry EP, Xie Y, Kennedy S, et al. Decreased hepatic triglyceride accumulation and altered fatty acid uptake in mice with deletion of the liver fatty acid-binding protein gene. J Biol Chem 2003;278:51664-51672 (Pubitemid 38020412)
9. Newberry EP, Xie Y, Kennedy SM, Luo J, Davidson NO. Protection against Western diet-induced obesity and hepatic steatosis in liver fatty acid-binding protein knockout mice. Hepatology 2006;44:1191-1205 (Pubitemid 44748370)
10. Jia S, Liu Z, Zhang S, et al. Essential roles of PI(3)K-p110beta in cell growth, metabolism and tumorigenesis. Nature 2008;454:776-779
11. Sopasakis VR, Liu P, Suzuki R, et al. Specific roles of the p110alpha isoform of phosphatidylinsositol 3-kinase in hepatic insulin signaling and metabolic regulation. Cell Metab 2010;11:220-230
12. Taniguchi CM, Kondo T, Sajan M, et al. Divergent regulation of hepatic glucose and lipid metabolism by phosphoinositide 3-kinase via Akt and PKClambda/zeta. Cell Metab 2006;3:343-353
13. Akimoto K, Takahashi R, Moriya S, et al. EGF or PDGF receptors activate atypical PKClambda through phosphatidylinositol 3-kinase. EMBO J 1996;15:788-798
14. Burgering BM, Coffer PJ. Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction. Nature 1995;376:599-602
15. Standaert ML, Galloway L, Karnam P, Bandyopadhyay G, Moscat J, Farese RV. Protein kinase C-zeta as a downstream effector of phosphatidylinositol 3-kinase during insulin stimulation in rat adipocytes. Potential role in glucose transport. J Biol Chem 1997;272:30075-30082 (Pubitemid 27512203)
16. Li X, Monks B, Ge Q, Birnbaum MJ. Akt/PKB regulates hepatic metabolism by directly inhibiting PGC-1alpha transcription coactivator. Nature 2007;447:1012-1016 (Pubitemid 46975750)
17. Matsumoto M, Ogawa W, Akimoto K, et al. PKClambda in liver mediates insulin-induced SREBP-1c expression and determines both hepatic lipid content and overall insulin sensitivity. J Clin Invest 2003;112:935-944 (Pubitemid 38063751)
18. Puigserver P, Rhee J, Donovan J, et al. Insulin-regulated hepatic gluconeogenesis through FOXO1-PGC-1alpha interaction. Nature 2003;423:550-555 (Pubitemid 36648580)
19. Leavens KF, Easton RM, Shulman GI, Previs SF, Birnbaum MJ. Akt2 is required for hepatic lipid accumulation in models of insulin resistance. Cell Metab 2009;10:405-418
20. Sajan MP, Standaert ML, Nimal S, et al. The critical role of atypical protein kinase C in activating hepatic SREBP-1c and NFkappaB in obesity. J Lipid Res 2009;50:1133-1145
21. Lu Z, Jiang YP, Wang W, et al. Loss of cardiac phosphoinositide 3-kinase p110 alpha results in contractile dysfunction. Circulation 2009;120:318-325
22. Ballou LM, Cross ME, Huang S, McReynolds EM, Zhang BX, Lin RZ. Differential regulation of the phosphatidylinositol 3-kinase/Akt and p70 S6 kinase pathways by the alpha(1A)-adrenergic receptor in rat-1 fibroblasts. J Biol Chem 2000;275:4803-4809 (Pubitemid 30108871)
23. Ballou LM, Tian PY, Lin HY, Jiang YP, Lin RZ. Dual regulation of glycogen synthase kinase-3beta by the alpha1A-adrenergic receptor. J Biol Chem 2001;276:40910-40916
24. Seglen PO. Preparation of isolated rat liver cells. Methods Cell Biol 1976;13:29-83
25. Waterfield CJ, Asker DS, Timbrell JA. Triglyceride disposition in isolated hepatocytes after treatment with hydrazine. Chem Biol Interact 1997;107:157-172 (Pubitemid 28020545)
26. Fan G, Jiang YP, Lu Z, et al. A transgenic mouse model of heart failure using inducible Galpha q. J Biol Chem 2005;280:40337-40346 (Pubitemid 41779171)
27. Barthel A, Schmoll D, Unterman TG. FoxO proteins in insulin action and metabolism. Trends Endocrinol Metab 2005;16:183-189 (Pubitemid 40603098)
28. Wu Q, Ortegon AM, Tsang B, Doege H, Feingold KR, Stahl A. FATP1 is an insulin-sensitive fatty acid transporter involved in diet-induced obesity. Mol Cell Biol 2006;26:3455-3467
29. Donnelly KL, Smith CI, Schwarzenberg SJ, Jessurun J, Boldt MD, Parks EJ. Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. J Clin Invest 2005;115:1343-1351 (Pubitemid 40629054)
30. Atshaves BP, Martin GG, Hostetler HA, McIntosh AL, Kier AB, Schroeder F. Liver fatty acid-binding protein and obesity. J Nutr Biochem 2010;21:1015-1032
31. Luxon BA, Milliano MT, Weisiger RA. Induction of hepatic cytosolic fatty acid binding protein with clofibrate accelerates both membrane and cytoplasmic transport of palmitate. Biochim Biophys Acta 2000;1487:309-318
32. Murphy EJ, Prows DR, Jefferson JR, Schroeder F. Liver fatty acid-binding protein expression in transfected fibroblasts stimulates fatty acid uptake and metabolism. Biochim Biophys Acta 1996;1301:191-198 (Pubitemid 26195792)
33. Li S, Brown MS, Goldstein JL. Bifurcation of insulin signaling pathway in rat liver: mTORC1 required for stimulation of lipogenesis, but not inhibition of gluconeogenesis. Proc Natl Acad Sci USA 2010;107:3441-3446
34. Chavez JA, Summers SA. Lipid oversupply, selective insulin resistance, and lipotoxicity: molecular mechanisms. Biochim Biophys Acta 2010;1801:252-265
35. Monetti M, Levin MC, Watt MJ, et al. Dissociation of hepatic steatosis and insulin resistance in mice overexpressing DGAT in the liver. Cell Metab 2007;6:69-78 (Pubitemid 46995777)